These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2856060)

  • 1. Effect of labetalol on human platelet function.
    Anfossi G; Trovati M; Lanzio M; Mularoni E; Massucco P; Emanuelli G
    Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):437-48. PubMed ID: 2856060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production.
    Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
    Arch Int Pharmacodyn Ther; 1990; 307():142-61. PubMed ID: 1982777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro.
    Prosdocimi M; Zatta A; Gorio A; Zanetti A; Dejana E
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):305-10. PubMed ID: 3012375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo.
    Trovati M; Anfossi G; Cavalot F; Massucco P; Mularoni E; Emanuelli G
    Diabetes; 1988 Jun; 37(6):780-6. PubMed ID: 2838353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
    Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW
    Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood.
    Anfossi G; Trovati M; Mularoni E; Massucco P; Calcamuggi G; Emanuelli G
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):1-7. PubMed ID: 2525784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
    Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
    Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet effects of protopine isolated from Corydalis tubers.
    Ko FN; Wu TS; Lu ST; Wu YC; Huang TF; Teng CM
    Thromb Res; 1989 Oct; 56(2):289-98. PubMed ID: 2559491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenaline infusion evokes increased thromboxane B2 production by platelets in healthy men: the effect of beta-adrenoceptor blockade.
    Laustiola K; Kaukinen S; Seppälä E; Jokela T; Vapaatalo H
    Eur J Clin Invest; 1986 Dec; 16(6):473-9. PubMed ID: 2881786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of trifluoperazine on platelet activation.
    Ardlie NG; Boatwright C; Garrett J; McGuiness JA
    Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by idebenone and the mechanism of the inhibition.
    Suno M; Terashita Z; Nagaoka A
    Arch Gerontol Geriatr; 1989 May; 8(3):313-21. PubMed ID: 2548448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
    Kerry R; Scrutton MC; Wallis RB
    Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced platelet release reaction and increased thromboxane generation in esophageal achalasia and selective in vitro inhibition of arachidonic acid induced platelet aggregation by vasoactive intestinal peptide.
    Zahavi M; Rozen P; Zahavi J
    Thromb Res; 1990 Aug; 59(3):693-9. PubMed ID: 2146767
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise.
    Sengeløv H; Winther K
    Eur J Clin Pharmacol; 1989; 37(5):453-7. PubMed ID: 2532135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a combined alpha- and beta-blocking drug, labetalol, on some aspects of platelet function.
    Lote K; Svenson B; Anstad U; Nordøy A
    Thromb Haemost; 1978 Oct; 40(2):423-7. PubMed ID: 734639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.